About
Technology
Issues
FAQ
Links
Official Page
Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability–High/Mismatch Repair–Deficient Metastatic Colorectal Cancer: KEYNOTE-164
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.